Neuphoria Therapeutics Inc. Diluted Shares Outstanding (Weighted Average)
Neuphoria Therapeutics Inc. (NEUP) reported Diluted Shares Outstanding (Weighted Average) of 4.40 million shares for the 12-month period ending 2026-06-30, per its 10-K filed 2026-09-18.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding · last filed 2026-09-18
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-06-30 was 5.41M shares, a 184.39% increase year-over-year.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2026-03-31 was 5.41M shares, a 214.78% increase year-over-year.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-12-31 was 4.54M shares, a 187.97% increase year-over-year.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for the quarter ending 2025-09-30 was 2.25M shares, a 72.77% increase year-over-year.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2026 was 4.40M shares, a 170.86% increase from fiscal 2025.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2025 was 1.62M shares, a 95.01% increase from fiscal 2024.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2024 was 832.23K shares, a 99.94% decline from fiscal 2023.
- Neuphoria Therapeutics Inc. weighted average number of shares outstanding, diluted for fiscal 2023 was 1.47B shares.
| Period end | Weighted Average Number of Shares Outstanding, Diluted 3 month | Weighted Average Number of Shares Outstanding, Diluted 3 month as first filed | Weighted Average Number of Shares Outstanding, Diluted 6 month | Weighted Average Number of Shares Outstanding, Diluted 9 month | Weighted Average Number of Shares Outstanding, Diluted 12 month | Weighted Average Number of Shares Outstanding, Diluted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2026-06-30 | 5.41M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-18 | 5.41M shares derived: average of 2 quarters · filed 2026-09-18 | 5.12M shares derived: average of 3 quarters · filed 2026-09-18 | 4.40M shares 10-K · filed 2026-09-18 | ||
| 2026-03-31 | 5.41M shares 10-Q · filed 2026-05-15 | 4.97M shares derived: average of 2 quarters · filed 2026-05-15 | 4.06M shares 10-Q · filed 2026-05-15 | 3.52M shares derived: average of 4 quarters · filed 2026-09-18 | ||
| 2025-12-31 | 4.54M shares 10-Q · filed 2026-02-17 | 3.39M shares 10-Q · filed 2026-02-17 | 2.89M shares derived: average of 3 quarters · filed 2026-09-18 | 2.60M shares derived: average of 4 quarters · filed 2026-09-18 | ||
| 2025-09-30 | 2.25M shares 10-Q · filed 2025-11-14 | 2.07M shares derived: average of 2 quarters · filed 2026-09-18 | 1.96M shares derived: average of 3 quarters · filed 2026-09-18 | 1.86M shares derived: average of 4 quarters · filed 2026-09-18 | ||
| 2025-06-30 | 1.90M shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-09-18 | 1.81M shares derived: average of 2 quarters · filed 2026-09-18 | 1.73M shares derived: average of 3 quarters · filed 2026-09-18 | 1.62M shares 10-K · filed 2026-09-18 | ||
| 2025-03-31 | 1.72M shares 10-Q · filed 2026-05-15 | 1.65M shares derived: average of 2 quarters · filed 2026-05-15 | 1.53M shares 10-Q · filed 2026-05-15 | 1.35M shares derived: average of 4 quarters · filed 2026-05-15 | ||
| 2024-12-31 | 1.58M shares 10-Q · filed 2026-02-17 | 1.44M shares 10-Q · filed 2026-02-17 | 1.23M shares derived: average of 3 quarters · filed 2026-02-17 | 1.16M shares derived: average of 4 quarters · filed 2026-02-17 | ||
| 2024-09-30 | 1.30M shares 10-Q · filed 2025-11-14 | 2.81B shares 10-Q · filed 2024-11-14 | 1.05M shares derived: average of 2 quarters · filed 2025-11-14 | 1.03M shares derived: average of 3 quarters · filed 2025-11-14 | 984.99K shares derived: average of 4 quarters · filed 2025-11-14 | |
| 2024-06-30 | 801.61K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | 891.32K shares derived: average of 2 quarters · filed 2025-09-29 | 879.97K shares derived: average of 3 quarters · filed 2025-09-29 | 832.23K shares 10-K · filed 2025-09-29 | 1.80B shares 10-K · filed 2024-09-30 | |
| 2024-03-31 | 981.04K shares 10-Q · filed 2025-05-20 | 919.15K shares derived: average of 2 quarters · filed 2025-05-20 | 842.43K shares 10-Q · filed 2025-05-20 | |||
| 2023-12-31 | 857.26K shares 10-Q · filed 2025-02-14 | 773.98K shares 10-Q · filed 2025-02-14 | ||||
| 2023-09-30 | 1.50B shares 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | 1.47B shares 10-K · filed 2024-09-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |